Additional studies demonstrated that IFNγ‐dependent resistance formation is independent from HLA I antigen expression in melanoma but also in K562 chronic myelogenous leukemia (CML) cells [15, 16]. The gene discussed is IFNG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.